Thrice-weekly ezetimibe cut LDL-C 20% in 33 statin-intolerant patients
A small study of 33 patients, mostly intolerant of other lipid drugs, found that dosing ezetimibe only three times a week still lowered LDL substantially, consistent with its 22-hour half-life. Most patients tolerated it.
